CAS NO: | 1300019-38-8 |
包装 | 价格(元) |
10mM (in 1mL DMSO) | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
Cas No. | 1300019-38-8 |
别名 | Molibresib carboxylic acid; GSK525762A carboxylic acid; PROTAC BRD4-binding moiety 2 |
Canonical SMILES | CC1=NN=C2[C@H](CC(O)=O)N=C(C3=CC=C(Cl)C=C3)C4=C(C=CC(OC)=C4)N21 |
分子式 | C20H17ClN4O3 |
分子量 | 396.83 |
溶解度 | DMSO : 7.14 mg/mL (17.99 mM) |
储存条件 | Store at -20°C |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | Target Protein-binding moiety 4 is a BRD4(1) inhibitor with an IC50 of 7.9 μM. Target Protein-binding moiety 4 (compound 32) is a BRD4 (1) inhibitor with an IC50 of 7.9 μM[1]. [1]. Yifei Yang, et al. Combined pharmacophore models as virtual screening protocol against BRD4(1) inhibitor. Medicinal Chemistry Research (2016), 25(4), 585-595. |